Cargando…

Defining care products to finance health care in the Netherlands

A case-mix project started in the Netherlands with the primary goal to define a complete set of health care products for hospitals. The definition of the product structure was completed 4 years later. The results are currently being used for billing purposes. This paper focuses on the methodology an...

Descripción completa

Detalles Bibliográficos
Autores principales: Westerdijk, Machiel, Zuurbier, Joost, Ludwig, Martijn, Prins, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286594/
https://www.ncbi.nlm.nih.gov/pubmed/21350859
http://dx.doi.org/10.1007/s10198-011-0302-6
_version_ 1782224574697439232
author Westerdijk, Machiel
Zuurbier, Joost
Ludwig, Martijn
Prins, Sarah
author_facet Westerdijk, Machiel
Zuurbier, Joost
Ludwig, Martijn
Prins, Sarah
author_sort Westerdijk, Machiel
collection PubMed
description A case-mix project started in the Netherlands with the primary goal to define a complete set of health care products for hospitals. The definition of the product structure was completed 4 years later. The results are currently being used for billing purposes. This paper focuses on the methodology and techniques that were developed and applied in order to define the casemix product structure. The central research question was how to develop a manageable product structure, i.e., a limited set of hospital products, with acceptable cost homogeneity. For this purpose, a data warehouse with approximately 1.5 million patient records from 27 hospitals was build up over a period of 3 years. The data associated with each patient consist of a large number of a priori independent parameters describing the resource utilization in different stages of the treatment process, e.g., activities in the operating theatre, the lab and the radiology department. Because of the complexity of the database, it was necessary to apply advanced data analysis techniques. The full analyses process that starts from the database and ends up with a product definition consists of four basic analyses steps. Each of these steps has revealed interesting insights. This paper describes each step in some detail and presents the major results of each step. The result consists of 687 product groups for 24 medical specialties used for billing purposes.
format Online
Article
Text
id pubmed-3286594
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-32865942012-03-08 Defining care products to finance health care in the Netherlands Westerdijk, Machiel Zuurbier, Joost Ludwig, Martijn Prins, Sarah Eur J Health Econ Original Paper A case-mix project started in the Netherlands with the primary goal to define a complete set of health care products for hospitals. The definition of the product structure was completed 4 years later. The results are currently being used for billing purposes. This paper focuses on the methodology and techniques that were developed and applied in order to define the casemix product structure. The central research question was how to develop a manageable product structure, i.e., a limited set of hospital products, with acceptable cost homogeneity. For this purpose, a data warehouse with approximately 1.5 million patient records from 27 hospitals was build up over a period of 3 years. The data associated with each patient consist of a large number of a priori independent parameters describing the resource utilization in different stages of the treatment process, e.g., activities in the operating theatre, the lab and the radiology department. Because of the complexity of the database, it was necessary to apply advanced data analysis techniques. The full analyses process that starts from the database and ends up with a product definition consists of four basic analyses steps. Each of these steps has revealed interesting insights. This paper describes each step in some detail and presents the major results of each step. The result consists of 687 product groups for 24 medical specialties used for billing purposes. Springer-Verlag 2011-02-25 2012 /pmc/articles/PMC3286594/ /pubmed/21350859 http://dx.doi.org/10.1007/s10198-011-0302-6 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Paper
Westerdijk, Machiel
Zuurbier, Joost
Ludwig, Martijn
Prins, Sarah
Defining care products to finance health care in the Netherlands
title Defining care products to finance health care in the Netherlands
title_full Defining care products to finance health care in the Netherlands
title_fullStr Defining care products to finance health care in the Netherlands
title_full_unstemmed Defining care products to finance health care in the Netherlands
title_short Defining care products to finance health care in the Netherlands
title_sort defining care products to finance health care in the netherlands
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286594/
https://www.ncbi.nlm.nih.gov/pubmed/21350859
http://dx.doi.org/10.1007/s10198-011-0302-6
work_keys_str_mv AT westerdijkmachiel definingcareproductstofinancehealthcareinthenetherlands
AT zuurbierjoost definingcareproductstofinancehealthcareinthenetherlands
AT ludwigmartijn definingcareproductstofinancehealthcareinthenetherlands
AT prinssarah definingcareproductstofinancehealthcareinthenetherlands